project id: TCGA-BLCA; case submitter id: TCGA-BT-A2LB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 73; days to birth: -26846; days to death: 492; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1937; age at diagnosis: 26846; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 170.0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: No; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 317; days to sample procurement: 0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0;